No CrossRef data available.
Article contents
Sex significantly predicts medial temporal volume when controlling for the influence of ApoE4 biomarker and demographic variables: A cross-ethnic comparison
Published online by Cambridge University Press: 30 June 2023
Abstract
Objective:
To explore the relationship between age, education, sex, and ApoE4 (+) status to brain volume among a cohort with amnestic mild cognitive impairment (aMCI).
Method:
One hundred and twenty-three participants were stratified into Hispanic (n = 75) and White non-Hispanic (WNH, N = 48). Multiple linear regression analyses were conducted with age, education, sex, and ApoE4 status as predictor variables and left and right combined MRI volumes of the hippocampus, parahippocampus, and entorhinal cortex as dependent variables. Variations in head sizes were corrected by normalization with a total intracranial volume measurement.
Results:
Bonferroni-corrected results indicated that when controlling for ApoE4 status, education, and age, sex was a significant predictor of hippocampal volume among the Hispanic group (β = .000464, R2 = .196, p < .01) and the WNH group (β = .000455, R2 = .195, p < .05). Education (β = .000028, R2 = .168, p < .01) and sex (β = .000261, R2 = .168, p < .01) were significant predictors of parahippocampal volume among the Hispanic MCI group when controlling for the effects of ApoE4 status and age. One-way ANCOVAs comparing hippocampal and parahippocampal volume between males and females within groups revealed that females had significantly larger hippocampal volumes (p < .05). Hispanic females had significantly larger hippocampal (p < .001) and parahippocampal (p < .05) volume compared to males. No sex differences in parahippocampal volume were noted among WNHs.
Conclusions:
Biological sex, rather than ApoE4 status, was a greater predictor of hippocampal volume among Hispanic and WNH females. These findings add to the mixed literature on sex differences in dementia research and highlight continued emphasis on ethnic populations to elucidate on neurodegenerative disparities.
Keywords
- Type
- Research Article
- Information
- Journal of the International Neuropsychological Society , Volume 30 , Issue 2 , February 2024 , pp. 128 - 137
- Copyright
- Copyright © INS. Published by Cambridge University Press 2023
References
Altmann, A., Tian, L., Henderson, V. W., Greicius, M. D., & Alzheimer’s Disease Neuroimaging Initiative Investigators (2014). Sex modifies the APOE-related risk of developing Alzheimer disease. Annals of Neurology, 75(4), 563–573.Google Scholar
Alzheimer’s Association (2020). Alzheimer’s disease facts and figures: Special report.Google Scholar
Arango-Lasprilla, J. C., Rivera, D., Aguayo, A., Rodríguez, W., Garza, M. T., Saracho, C. P., Rodríguez-Agudelo, Y., Aliaga, A., Weiler, G., Luna, M., Longoni, M., Ocampo-Barba, N., Galarza-del-Angel, J., Panyavin, I., Guerra, A., Esenarro, L., García de la Cadena, P., Martínez, C., Perrin, P. B., & Arango-Lasprilla, J. C. (2015). Trail Making Test: Normative data for the Latin American Spanish speaking adult population. NeuroRehabilitation, 37(4), 639–661.Google Scholar
Arango-Lasprilla, J. C., Rivera, D., Garza, M. T., Saracho, C. P., Rodríguez, W., Rodríguez-Agudelo, Y., Aguayo, A., Schebela, S., Luna, M., Longoni, M., Martínez, C., Doyle, S., Ocampo-Barba, N., Galarza-del-Angel, J., Aliaga, A., Bringas, M., Esenarro, L., García-Egan, P., Perrin, P. B., & Arango-Lasprilla, J. C. (2015). Hopkins verbal learning test-revised: Normative data for the Latin American Spanish speaking adult population. NeuroRehabilitation, 37(4), 699–718.Google Scholar
Benson, G., Felipe, J. A., Xiaodong, , & Sano, M. (2014). Performance of Spanish-speaking community-dwelling elders in the United States on the Uniform Data Set. Alzheimer’s & Dementia, 10(5S), S338–S343.Google Scholar
Benton, A. L. (1968). Differential behavioral effects in frontal lobe disease. Neuropsychologia, 6(1), 53–60.Google Scholar
Benton, A. L., Sivan, A. B., Hamsher, K. D., Varney, N. R., & Spreen, O. (1994). Contributions to neuropsychological assessment: A clinical manual. Oxford University Press.Google Scholar
Beydoun, M. A., Boueiz, A., Abougergi, M. S., Kitner-Triolo, M. H., Beydoun, H. A., Resnick, S. M., O'Brien, R., & Zonderman, A. B. (2012). Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline. Neurobiology of Aging, 33(4), 720–731.Google Scholar
Bilbul, M., & Schipper, H. M. (2011). Risk profiles of Alzheimer disease. Canadian Journal of Neurological Sciences, 38(4), 580–392.Google Scholar
Bird, T. D. (1993). Alzheimer’s disease overview. In Adam, M. P., Ardinger, H. H., Pagon, R. A., Wallance, S. E., Bean, L. J. H., Stephens, K., & Amemiya, A. (Eds.), GeneReviews. University of Washington.Google Scholar
Borenstein, A. R., Mortimer, J. A., Wu, Y., Jureidini-Webb, F. M., Fallin, M. D., Small, B. J., Mullan, M., & Crawford, F. C. (2006). Apolipoprotein E and cognition in community-based samples of African Americans and Caucasians. Ethnicity & Disease, 16, 9.Google Scholar
Brandt, J. (1991). The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms. The Clinical Neuropsychologist, 5(2), 125–142.Google Scholar
Breitner, J. C. S., Wyse, B. W., Anthony, J. C., Welsh-Bohmer, K. A., Steffens, D. C., Norton, M. C., Tschanz, J. T., Plassman, B. L., Meyer, M. R., Skoog, I., & Khachaturian, A. (1999). APOE-ϵ4 count predicts age when prevalence of AD increases, then declines: The Cache County Study. Neurology, 53(2), 321–321.Google Scholar
Brickman, A. M., Honig, L. S., Scarmeas, N., Tatarina, O., Sanders, L., Albert, M. S., Brandt, J., Blacker, D., & Stern, Y. (2008). Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Archives of Neurology, 65(9), 1208.Google Scholar
Burgren, A. C., Zeineh, M. M., Ekstrom, A. D., Braskie, M. N., Thompson, P. M., Small, G. W., & Bookheimer, S. Y. (2008). Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage, 41(4), 1177–1183.Google Scholar
Burke, S. L., Hu, T., Fava, N. M., Li, T., Rodriguez, M. J., Schuldiner, K. L., Burgess, A., & Laird, A. (2019). Sex differences in the development of mild cognitive impairment and probable Alzheimer’s disease as predicted by hippocampal volume or white matter hyperintensities. Journal of Women & Aging, 31(2), 140–164.Google Scholar
Campos, M., Edland, S. D., & Peavy, G. M. (2014). An exploratory study of ApoE4 genotype and risk of Alzheimer Disease in Mexican Hispanics. Journal of American Pediatric Society, 61(6), 1038–1040.Google Scholar
Chartier-Harlin, M. C., Parfitt, M., Legrain, S., Perez-Tur, J., Brousseau, T., Evans, A., Berr, C., Vidal, O., Roques, P., & Gourlet, V. (1994). Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer’s disease: Analysis of the 19q13.2 chromosomal region. Human Molecular Genetics, 3(4), 569–574.Google Scholar
Conomos, M. P., Laurie, C. A., Stilp, A. M., Gogarten, S. M., McHugh, C. P., Nelson, S. C., Sofer, T., Fernández-Rhodes, L., Justice, A. E., Graff, M., Young, K. L., Seyerle, A. A., Avery, C. L., Taylor, K. D., Rotter, J. I., Talavera, G. A., Daviglus, M. L., Wassertheil-Smoller, S., Schneiderman, N., …Laurie, C. C. (2016). Genetic diversity and association studies in US Hispanic/Latino populations: Applications in the Hispanic Community Health Study/Study of Latinos. The American Journal of Human Genetics, 98(1), 165–184.Google Scholar
De Oliveira, F. F., Bertolucci, P. H., Chen, E. S., & Smith, M. C. (2014). Risk factors for age at onset of dementia due to Alzheimer’s disease in a sample of patients with low mean schooling from São Paulo. Brazil International Journal of Geriatric Psychiatry, 29(10), 1033–1039.Google Scholar
De Oliveira, F. F., Chen, E. S., Smith, M., & Bertolucci, P. H. (2017). Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer’s disease dementia. Revista brasilaira de Psychiatria, 39, 95–103.Google Scholar
Driscoll, I., Davatzikos, C., An, Y., Wu, X., Shen, D., Kraut, M., & Resnick, S. (2009). Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology, 72(22), 1906–1913.CrossRefGoogle ScholarPubMed
Duara, R., Barker, W., Lopez-Alberola, R., & Loewenstein, D. A. (1996). Alzheimer’s disease: Interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology, 46(6), 1575–1579.Google Scholar
Duara, R., Loewenstein, D. A., Lizarraga, G., Adjouadi, M., Barker, W. W., Greig-Custo, M. T., Rosselli, M., Penate, A., Shea, Y. F., Behar, R., Ollarves, A., Robayo, C., Hanson, K., Marsiske, M., Burke, S., Ertekin-Taner, N., Vaillancourt, D., De Santi, S., Golde, T., & DeKosky, S. T. (2019). Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity. NeuroImage: Clinical, 22, 101800.Google Scholar
Edwards, D. P. (2005). Regulation of signal transduction pathways by estrogen and progesterone. Annual Review of Physiology, 67(1), 335–376.Google Scholar
Farrer, L. A., Cupples, L. A., Hainess, J. L., Hyman, B., KuKull, W. A., Mayeux, R., Myers, R. H., Pericak-Vance, M. A., Risch, N., & Dujin, R. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 278(16), 1349–1356.Google Scholar
Fouquet, M., Besson, F. L., Gonneaud, J., La Joie, R., & Chetelat, G. (2014). Imaging brain effects of ApoE4 in cognitively normal individuals across the lifespan. Neuropsychology Review, 24(33), 290–299.Google Scholar
Gao, Z., Chen, Z., Sun, A., & Deng, X. (2019). Gender differences in cardiovascular disease. Medicine in Novel Technology and Devices, 4, 100025.Google Scholar
Gatz, M., Pederson, N. L., Berg, S., Johansson, B., Johansson, K., Mortimer, J. A., Posner, S. F., Viitanen, M., Winblad, B., & Ahlbom, A. (1997). Heritability for Alzheimer’s disease: The study of dementia in Swedish twins. Journal of Gerontology, 52A(2), M117–M125.Google Scholar
González, H. M., Tarraf, W., Jian, X., Vásquez, P. M., Kaplan, R., Thyagarajan, B., Daviglus, M., Lamar, M., Gallo, L. C., Zeng, D., & Fornage, M. (2018). Apolipoprotein E genotypes among diverse middle-aged and older Latinos: Study of Latinos-Investigation of Neurocognitive Aging results (HCHS/SOL). Scientific Reports, 8(1), 1–6.Google Scholar
Gur, R. C., Gunning-Dixon, F. M., Turetsky, B. I., Bilker, W. B., & Gur, R. E. (2002). Brain region and sex differences in age association with brain volume: A quantitative MRI study of healthy young adults. The American Journal of Geriatric Psychiatry, 10(1), 72–80.Google Scholar
Hebert, L. E., Scherr, P. A., McCann, J. J., Beckett, L. A., & Evans, D. A. (2001). Is the risk of developing Alzheimer’s disease greater for women than for men? American Journal of Epidemiology, 153(2), 132–136.Google Scholar
Huynh, T. V., Davis, A. A., Ulrich, J. D., & Holtzman, D. M. (2017). Apolipoprotein E and Alzheimer disease: The influence of apoE on amyloid-B and other amyloidogenic proteins. Journal of Lipid Research, 58(5), 824–836.Google Scholar
Ishunina, T. A., Fischer, D. F., & Swaab, D. F. (2007). Estrogen receptor α and its splice variants in the hippocampus in aging and Alzheimer’s disease. Neurobiology of Aging, 28(11), 1670–1681.Google Scholar
Kim, D. H., Yeo, S. H., Park, J.-M., Choi, J. Y., Lee, T.-H., Park, S. Y., Ock, M. S., Eo, J., Kim, H.-S., & Cha, H.-J. (2014). Genetic markers for diagnosis and pathogenesis of Alzheimer’s disease. Gene, 545(2), 185–193.Google Scholar
Kim, J., Castellano, J. M., Jiang, H., Basak, J. M., Parsadanian, M., Pham, V., Mason, S. M., Paul, S. M., & Holtzman, D. M. (2009). Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular Aβ clearance. Neuron, 64(5), 632–644.Google Scholar
Langbaum, J. B. S., Chen, K., Caselli, R. J., Lee, W., Reschke, C., Bandy, D., Alexander, G. E., Burns, C. M., Kaszniak, A. W., Reeder, S. A., Corneveaux, J. J., Allen, A. N., Pruzin, J., Huentelman, M. J., Fleisher, A. S., & Reiman, E. M. (2010). Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E ϵ4 allele. Archives of Neurology, 67(4), 462–468.Google Scholar
Lehmann, D. J., Refsum, H., Nurk, E., Warden, D. R., Tell, G. S., Vollset, S. E., Engedal, K., Nygaard, H. A., & Smith, A. D. (2006). Apolipoprotein E ϵ4 and impaired episodic memory in community-dwelling elderly people: A marked sex difference. The Hordaland Health Study. Journal of Neurology, Neurosurgery & Psychiatry, 77(8), 902–908.Google Scholar
Liu, C. C., Liu, C. C., Kanekiyo, T., & Bu, G. (2013). Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nature Review Neurology, 9(2), 106–118.Google Scholar
Loewenstein, D. A., Curiel, R. E., DeKosky, S., Bauer, R. M., Rosselli, M., Guinjoan, S. M., Adjouadi, M., Peñate, A., Barker, W. W., Goenaga, S., Golde, T., Greig-Custo, M. T., Hanson, K. S., Li, C., Lizarraga, G., Marsiske, M., & Duara, R. (2018). Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment. Neurology, 91(10), e976–e984.Google Scholar
Loewenstein, D. A., Curiel, R. E., Wright, C., Sun, X., Alperin, N., Crocco, E., Czaja, S. J., Raffo, A., Penate, A., Melo, J., Capp, K., Gamez, M., & Duara, R. (2017). Recovery from proactive semantic interference in mild cognitive impairment and normal aging: Relationship to atrophy in brain regions vulnerable to Alzheimer’s disease. Journal of Alzheimer’s Disease, 56(3), 1119–1126.Google Scholar
Michaelson, D. M. (2014). APOE epsilon4: The most prevalent yet understudied risk factor for Alzheimer’s disease. Alzheimer’s & Dementia, 10(6), 861–868.Google Scholar
Mortensen, E. L., & Høgh, P. (2001). A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology, 57(1), 89–95.Google Scholar
Mungas, D., Fletcher, E., & de Carli, C. (2015). Ethnic/racial differences in brain mechanisms of cognitive decline. Alzheimer’s & Dementia, 11(7), P116.Google Scholar
Mungas, D., Gavett, B., Fletcher, E., Farias, S. T., DeCarli, C., & Reed, B. (2018). Education amplifies brain atrophy effect on cognitive decline: Implications for cognitive reserve. Neurobiology of Aging, 68, 142–150.Google Scholar
Neu, S. C., Pa, J., Kukull, W., Beekly, D., Kuzma, A., Gangadharan, P., Want, L., Romero, K., & Arneric, S. (2017). Apolipoprotein E genotype and sex risk factors for Alzheimer’s disease. JAMA, 74(10), 1178–1189. https://doi.org/10.1001/jamaneurol.2017.2188
Google Scholar
Nyberg, L., Magnussen, F., Lundquist, A., Baaré, W., Bartrés-Faz, D., Bertram, L., Boraxbekk, C. J., Brandmaier, A. M., Drevon, C. A., Ebmeier, K., Ghisletta, P., Henson, R. N., Junqué, C., Kievit, R., Kleemeyer, M., Knights, E., Kühn, S., Lindenberger, U., Penninx, B. W., …Fjell, A. M. (2021). Educational attainment does not influence brain aging. Proceedings of the National Academy of Sciences, 118(18), e2101644118.Google Scholar
O'Bryant, S. E., Johnson, L., Reisch, J., Edwards, M., Hall, J., Barber, R., Devous, M. D. Sr., Royall, D., & Singh, M. (2013). Risk factors for mild cognitive impairment among Mexican Americans. Alzheimer’s & Dementia, 9(6), 622–631.Google Scholar
O'Dwyer, L., Lamberton, F., Matura, S., Tanner, C., Scheibe, M., Miller, J., Rujescu, D., Prvulovic, D., Hampel, H., & Stamatakis, E. A. (2012). Reduced hippocampal volume in healthy young ApoE4 carriers: An MRI study. PloS One, 7(11), e48895.Google Scholar
Ostrosky-Solís, F., Ardila, A., & Rosselli, M. (1999). NEUROPSI: A brief neuropsychological test battery in Spanish with norms by age and educational level. Journal of the International Neuropsychological Society, 5(5), 413–433.Google Scholar
Palloni, A., & Arias, E. (2004). Paradox lost: Explaining the Hispanic adult mortality advantage. Demography, 41(3), 385–415.Google Scholar
Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183–194.CrossRefGoogle ScholarPubMed
Qiu, C., Bäckman, L., Winblad, B., Agüero-Torres, H., & Fratiglioni, L. (2001). The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen project. Archives of Neurology, 58(12), 2034–2039. https://doi.org/10.1001/archneur.58.12.2034
Google Scholar
Rahman, A., Jackson, H., Hristov, H., Isaacson, R. S., Saif, N., Shetty, T., Etingin, O., Henchcliffe, C., Brinton, R. D., & Mosconi, L. (2019). Sex and gender driven modifiers of Alzheimer’s: The role for estrogenic control across age, race, medical, and lifestyle risks. Frontiers in Aging Neuroscience, 11, 315.Google Scholar
Reitan, R. M. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8(3), 271–276.Google Scholar
Richey, P. L., Siedlak, S. L., Smith, M. A., & Perry, G. (1995). Apolipoprotein E interaction with neurofibrillary tangles and senile plaques in Alzheimer’s disease: Implication for disease pathogenesis. Biochemical and Biophysical Research Communications, 208(2), 657–663.Google Scholar
Riedel, B. C., Thompson, P. M., & Brinton, R. D. (2016). Age, APOE and sex: Triad of risk of Alzheimer’s disease. The Journal of Steroid Biochemistry and Molecular Biology, 160, 134–147. https://doi.org/10.1016/j.jsbmb.2016.03.012
Google Scholar
Rogaeva, E., Tandon, A., & Georger-Hyslop, P. H. S. (2001). Genetic markers in the diagnosis of Alzheimer’s disease. Journal of Alzheimer’s Disease, 3(3), 293–304.Google Scholar
Ryan, J., Carrière, I., Carcaillon, L., Dartigues, J.‐F., Auriacombe, S., Rouaud, O., Berr, C., Ritchie, K., Scarabin, P.‐Y., & Ancelin, M.‐L. (2014). Estrogen receptor polymorphisms and incident dementia: The prospective 3C study. Alzheimer’s & Dementia, 10(1), 27–35.Google Scholar
Schipper, H. M. (2011). Apolipoprotein E: Implications for AD neurobiology, epidemiology, and risk assessment. Neurobiology of Aging, 32(5), 778–790.Google Scholar
Sevush, S., Peruyera, G., Crawford, F., & Mullan, M. (2000). Apolipoprotein-E ε4 allele frequency and conferred risk for Cuban Americans with Alzheimer’s disease. The American Journal of Geriatric Psychiatry, 8(3), 254–256.Google Scholar
Snyder, H. M., Asthana, S., Bain, L., Brinton, R., Craft, S., Dubal, D. B., Espeland, M. A., Gatz, M., Mielke, M. M., Raber, J., Rapp, P. R., Yaffe, K., & Carrillo, M. C. (2016). Sex biology contributions to vulnerability to Alzheimer’s disease: A think tank convened by the Women’s Alzheimer’s Research Initiative. Alzheimer’s & Dementia, 12(11), 1186–1196.Google Scholar
Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18(6), 643–662.Google Scholar
Tang, M-X., Cross, P., Andrews, H., Jacobs, D. M., Small, S., Bell, K., Merchant, C., Lantigua, R., Costa, R., Stern, Y., & Mayeux, R. (2001). Incidence of AD in African-Americans, Caribbean hispanics, and caucasians in northern Manhattan. Neurology, 56(1), 49–56.Google Scholar
Tang, M. X., Stern, Y., Marder, K., Bell, K., Gurland, B., Lantigua, R., Andrews, H., Feng, L., Tycko, B., & Mayeux, R. (1998). The APOE- 4 allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics. JAMA, 279(10), 751–755.Google Scholar
U.S. Census Bureau (2017). Table 4, Projected Race and Hispanic Origin: Main Projections Series for the United States, 2017-2060. [Excel] Population Division.Google Scholar
Vila-Castelar, C., Guzmán-Vélez, E., Pardilla-Delgado, E., Buckley, R. F., Bocanegra, Y., Baena, A., Fox-Fuller, J. T., Tirado, V., Muñoz, C., Giraldo, M., Acosta-Baena, N., Rios-Romenets, S., Langbaum, J. B., Tariot, P. N., Lopera, F., Reiman, E. M., Quiroz, Y. T., & Kirkland Caldwell, J. (2020). Examining sex differences in markers of cognition and neurodegeneration in autosomal dominant Alzheimer’s disease: Preliminary findings from the Colombian Alzheimer’s Prevention Initiative Biomarker Study. Journal of Alzheimer’s Disease, 77(4), 1743–1753.Google Scholar
Wechsler, D. (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). NCS Pearson.Google Scholar
Williams, O. A., An, Y., Beason-Held, L., Huo, Y., Ferrucci, L., Landman, B. A., & Resnick, S. M. (2019). Vascular burden and APOE ϵ4 are associated with white matter microstructural decline in cognitively normal older adults. NeuroImage, 188, 572–583.Google Scholar
Yaffe, K., Haan, M., Byers, A., Tangen, C., & Kuller, L. M. D. D. (2000). Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction. Neurology, 54(10), 1949–1954.Google Scholar
Yu, L., Lutz, M. W., Wilson, R. S., Burns, D. K., Roses, A. D., Saunders, A. M., Yang, J., Gaiteri, C., De Jager, P. L., Barnes, L. L., Bennett, D. A., & Toft, M. (2017). APOE ϵ4-TOMM40 523 haplotypes and the risk of Alzheimers disease in older Caucasian and African Americans. PloS One, 12(7), e0180356.Google Scholar
Zárate, S., Stevnsner, T., & Gredilla, R. (2017). Role of estrogen and other sex hormones in brain aging. Neuroprotection and DNA repair. Frontiers in Aging Neuroscience, 9, 430.Google Scholar
Zissimopoulos, J. M., Barthold, D., Brinton, R. D., & Joyce, G. (2017). Sex and race differences in the association between statin use and the incidence of Alzheimer disease. JAMA Neurology, 74(2), 225–232.Google Scholar